Compare AANJANEYA LIFECARE with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS STERLING BIOTECH DR. DATSONS LABS/
STERLING BIOTECH
 
P/E (TTM) x -10.9 -0.4 - View Chart
P/BV x 0.2 0.0 1,139.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   STERLING BIOTECH
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
STERLING BIOTECH
Dec-13
DR. DATSONS LABS/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs12611 1,196.2%   
Low Rs313 908.8%   
Sales per share (Unadj.) Rs133.026.8 496.1%  
Earnings per share (Unadj.) Rs0.2-15.0 -1.0%  
Cash flow per share (Unadj.) Rs6.6-5.5 -121.0%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.854.9 234.7%  
Shares outstanding (eoy) m31.66267.87 11.8%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.3 226.9%   
Avg P/E ratio x516.1-0.5 -111,073.4%  
P/CF ratio (eoy) x11.8-1.3 -930.8%  
Price / Book Value ratio x0.60.1 479.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4771,862 133.1%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m56547 10.2%   
Avg. sales/employee Rs ThNM5,303.3-  
Avg. wages/employee Rs ThNM403.8-  
Avg. net profit/employee Rs ThNM-2,959.0-  
INCOME DATA
Net Sales Rs m4,2117,181 58.6%  
Other income Rs m7943 184.7%   
Total revenues Rs m4,2897,223 59.4%   
Gross profit Rs m569947 60.0%  
Depreciation Rs m2042,543 8.0%   
Interest Rs m4304,377 9.8%   
Profit before tax Rs m13-5,931 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-1,924 -0.3%   
Profit after tax Rs m5-4,007 -0.1%  
Gross profit margin %13.513.2 102.4%  
Effective tax rate %48.032.4 148.0%   
Net profit margin %0.1-55.8 -0.2%  
BALANCE SHEET DATA
Current assets Rs m6,85214,335 47.8%   
Current liabilities Rs m6,71149,809 13.5%   
Net working cap to sales %3.3-494.0 -0.7%  
Current ratio x1.00.3 354.8%  
Inventory Days Days161403 39.9%  
Debtors Days Days318171 186.6%  
Net fixed assets Rs m3,67355,432 6.6%   
Share capital Rs m317268 118.2%   
"Free" reserves Rs m3,76113,935 27.0%   
Net worth Rs m4,07814,701 27.7%   
Long term debt Rs m1,6719,478 17.6%   
Total assets Rs m12,63373,988 17.1%  
Interest coverage x1.0-0.4 -290.0%   
Debt to equity ratio x0.40.6 63.6%  
Sales to assets ratio x0.30.1 343.4%   
Return on assets %3.40.5 687.5%  
Return on equity %0.1-27.3 -0.4%  
Return on capital %7.7-6.4 -119.4%  
Exports to sales %22.925.9 88.4%   
Imports to sales %14.30.2 8,413.9%   
Exports (fob) Rs m9641,860 51.8%   
Imports (cif) Rs m60212 4,933.6%   
Fx inflow Rs m9641,860 51.8%   
Fx outflow Rs m60725 2,439.1%   
Net fx Rs m3571,835 19.5%   
CASH FLOW
From Operations Rs m1,3451,719 78.2%  
From Investments Rs m-2,256-3,148 71.6%  
From Financial Activity Rs m-1,2001,426 -84.1%  
Net Cashflow Rs m-2,111-3 62,079.4%  

Share Holding

Indian Promoters % 4.5 33.9 13.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 1.4 9.9 13.6%  
ADR/GDR % 0.0 16.9 -  
Free float % 94.1 39.3 239.4%  
Shareholders   20,807 21,482 96.9%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  GSK PHARMA  UNICHEM LAB  ORCHID PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 300 Points Lower; Dow Futures Down by 101 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 385 points, down 0.8% at 51,059 levels.

Related Views on News

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS